{
    "title": "Reducing Marketplace Interference Bias Via Shadow Prices. (arXiv:2205.02274v3 [math.OC] UPDATED)",
    "abstract": "Marketplace companies rely heavily on experimentation when making changes to the design or operation of their platforms. The workhorse of experimentation is the randomized controlled trial (RCT), or A/B test, in which users are randomly assigned to treatment or control groups. However, marketplace interference causes the Stable Unit Treatment Value Assumption (SUTVA) to be violated, leading to bias in the standard RCT metric. In this work, we propose techniques for platforms to run standard RCTs and still obtain meaningful estimates despite the presence of marketplace interference. We specifically consider a generalized matching setting, in which the platform explicitly matches supply with demand via a linear programming algorithm. Our first proposal is for the platform to estimate the value of global treatment and global control via optimization. We prove that this approach is unbiased in the fluid limit. Our second proposal is to compare the average shadow price of the treatment and ",
    "link": "http://arxiv.org/abs/2205.02274",
    "context": "Title: Reducing Marketplace Interference Bias Via Shadow Prices. (arXiv:2205.02274v3 [math.OC] UPDATED)\nAbstract: Marketplace companies rely heavily on experimentation when making changes to the design or operation of their platforms. The workhorse of experimentation is the randomized controlled trial (RCT), or A/B test, in which users are randomly assigned to treatment or control groups. However, marketplace interference causes the Stable Unit Treatment Value Assumption (SUTVA) to be violated, leading to bias in the standard RCT metric. In this work, we propose techniques for platforms to run standard RCTs and still obtain meaningful estimates despite the presence of marketplace interference. We specifically consider a generalized matching setting, in which the platform explicitly matches supply with demand via a linear programming algorithm. Our first proposal is for the platform to estimate the value of global treatment and global control via optimization. We prove that this approach is unbiased in the fluid limit. Our second proposal is to compare the average shadow price of the treatment and ",
    "path": "papers/22/05/2205.02274.json",
    "total_tokens": 884,
    "translated_title": "通过影子价格降低市场干扰偏差",
    "translated_abstract": "市场公司在设计或运营其平台时 heavily 依赖实验。实验的核心是随机对照试验（RCT）或 A/B 测试，即将用户随机分配到治疗组或对照组。然而，市场干扰导致稳定单元治疗价值假设 (SUTVA) 被违反，从而导致标准 RCT 指标的偏差。在这项工作中，我们提出了平台在存在市场干扰的情况下运行标准 RCT 并获得有意义估计的技术。我们特别考虑广义匹配设置，其中平台通过线性规划算法明确匹配供应和需求。我们的第一个提议是通过优化估计全局治疗和全局对照的价值。我们证明了这种方法在流体极限中是无偏的。我们的第二个提议是比较治疗组和",
    "tldr": "这项工作提出了在市场干扰存在的情况下运行标准实验并获得无偏估计的技术。通过优化估计全局治疗和全局对照的价值，并比较治疗组和影子价格的平均值，实现了降低市场干扰偏差。"
}